ArticleInternational journal of clinical oncology2026

Real-world effectiveness and safety of lisocabtagene maraleucel for relapsed/refractory large B cell lymphoma in Japan.

Tetsuro Ochi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.